
    
      Study design: Prospective, single arm

      Timeline: six month enrollment period and 12 months follow-up period.

      Sites: The study will be conducted at McGill University.

      Study population: Ten adult patients diagnosed with facet related low back pain.

      Primary study objective: Safety and efficacy of the Neurolyser XR for the treatment of facet
      related low back pain.

      Safety would be evaluated by the incidence and severity of treatment related adverse events
      Efficacy would be evaluated by the changes in average pain score and Rolland Morris
      Disability Questionnaire between baseline and 6 months.
    
  